SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Jun-24 4:14 PM View: | Eli Lilly & Co. (LLY) | 03-Jun-24 | Private Sale (Planned) | 7,056 | $819.38 | $5,781,550.00 | (20%) 34.78K to 27.73K | |
14-Feb-24 4:19 PM View: | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 1,668 | $737.26 | $1,229,750.00 | 5% 33.12K to 34.78K | |
02-Feb-24 10:00 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-24 | Payment of Exercise | 566 | $645.61 | $365,415.00 | (2%) 33.68K to 33.12K | |
02-Feb-24 10:00 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-24 | Option Exercise | 1,268 | -- | -- | 4% 32.41K to 33.68K | |
15-Jun-23 4:21 PM View: | Eli Lilly & Co. (LLY) | 15-Jun-23 | Sale (Planned) | 1,647 | $448.00 | $737,856.00 | (5%) 34.05K to 32.41K | |
15-Jun-23 4:21 PM View: | Eli Lilly & Co. (LLY) | 14-Jun-23 | Private Sale (Planned) | 1,647 | $444.29 | $731,746.00 | (5%) 35.7K to 34.05K | |
21-Feb-23 4:32 PM View: | Eli Lilly & Co. (LLY) | 17-Feb-23 | Gift | 500 | -- | -- | (1%) 36.19K to 35.69K | |
14-Feb-23 4:52 PM View: | Eli Lilly & Co. (LLY) | 10-Feb-23 | Grant | 2,507 | $345.12 | $865,216.00 | 7% 33.68K to 36.19K | |
03-Feb-23 4:54 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-23 | Payment of Exercise | 941 | $344.15 | $323,845.00 | (3%) 34.63K to 33.68K | |
03-Feb-23 4:54 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-23 | Option Exercise | 2,102 | -- | -- | 6% 32.52K to 34.63K | |
11-Feb-22 6:22 PM View: | Eli Lilly & Co. (LLY) | 09-Feb-22 | Grant | 3,294 | $243.27 | $801,331.00 | 11% 30.26K to 33.56K | 7% |
03-Feb-22 4:59 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-22 | Payment of Exercise | 1,194 | $245.39 | $292,996.00 | (4%) 31.46K to 30.26K | |
03-Feb-22 4:59 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-22 | Option Exercise | 2,676 | -- | -- | 9% 28.78K to 31.46K | |
10-Feb-21 8:36 PM View: | Eli Lilly & Co. (LLY) | 08-Feb-21 | Grant | 6,040 | $205.77 | $1,242,850.00 | 27% 22.7K to 28.74K | (2%) |
03-Feb-21 6:38 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-21 | Payment of Exercise | 1,529 | $207.97 | $317,986.00 | (6%) 24.23K to 22.7K | |
03-Feb-21 6:38 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-21 | Option Exercise | 3,435 | -- | -- | 17% 20.79K to 24.23K | |
02-Feb-21 10:00 PM View: | Eli Lilly & Co. (LLY) | 28-Apr-20 | Gift | 156 | -- | -- | (< 1%) 20.95K to 20.8K | |
18-Mar-20 10:44 AM View: | Eli Lilly & Co. (LLY) | 16-Mar-20 | Market Sale (Planned) | 4,727 | $131.00 | $619,237.00 | (18%) 25.64K to 20.91K | (25%) |
18-Feb-20 2:57 PM View: | Eli Lilly & Co. (LLY) | 16-Feb-20 | Payment of Exercise | 34 | $141.12 | $4,798.08 | (< 1%) 25.66K to 25.62K | (16%) |
18-Feb-20 2:57 PM View: | Eli Lilly & Co. (LLY) | 16-Feb-20 | Option Exercise | 97 | -- | -- | < 1% 25.56K to 25.66K | |
13-Feb-20 5:46 PM View: | Eli Lilly & Co. (LLY) | 11-Feb-20 | Grant | 1,778 | $144.25 | $256,476.00 | 7% 23.78K to 25.56K | 13% |
03-Feb-20 10:00 PM View: | Eli Lilly & Co. (LLY) | 07-Mar-19 | Gift | 196 | -- | -- | (< 1%) 23.98K to 23.78K | |
20-Feb-19 3:52 PM View: | Eli Lilly & Co. (LLY) | 16-Feb-19 | Payment of Exercise | 17 | $122.48 | $2,082.16 | (< 1%) 23.93K to 23.92K | (34%) |
20-Feb-19 3:52 PM View: | Eli Lilly & Co. (LLY) | 16-Feb-19 | Option Exercise | 48 | -- | -- | < 1% 23.89K to 23.93K | |
06-Feb-19 7:22 PM View: | Eli Lilly & Co. (LLY) | 04-Feb-19 | Grant | 2,958 | $120.17 | $355,463.00 | 14% 20.93K to 23.88K | 36% |
06-Nov-18 1:25 PM View: | Eli Lilly & Co. (LLY) | 03-Nov-18 | Payment of Exercise | 1,366 | $106.75 | $145,820.00 | (6%) 22.28K to 20.91K | (52%) |
06-Nov-18 1:25 PM View: | Eli Lilly & Co. (LLY) | 03-Nov-18 | Option Exercise | 3,133 | -- | -- | 16% 19.15K to 22.28K | |
21-Feb-18 10:28 AM View: | Eli Lilly & Co. (LLY) | 16-Feb-18 | Payment of Exercise | 14 | $78.02 | $1,092.28 | (< 1%) 19.11K to 19.1K | (106%) |
21-Feb-18 10:28 AM View: | Eli Lilly & Co. (LLY) | 16-Feb-18 | Option Exercise | 48 | -- | -- | < 1% 19.06K to 19.11K | |
31-Jan-18 6:08 PM View: | Eli Lilly & Co. (LLY) | 29-Jan-18 | Grant | 1,599 | $87.60 | $140,072.00 | 9% 17.46K to 19.06K | 82% |